PYX MARKETS LIMITED

Financial Health Score: F (Critical Condition)

PYX MARKETS LIMITED is in critical financial condition, displaying severe symptoms of balance sheet insolvency. The company’s liabilities vastly exceed its assets, and it possesses almost zero liquidity to operate independently. It is currently surviving on life support in the form of long-term creditor support, almost certainly from its parent companies, with no signs of organic financial recovery.

Key Vital Signs

• Net Assets (Equity): -£712,601 The company’s skeletal structure is fundamentally fractured. Net assets are deeply negative, meaning the company owes more than it owns. This is a worsening chronic condition, deteriorating from -£619,101 in 2023 and -£347,284 a decade ago.
• Current Assets: £225 The patient has virtually no pulse when it comes to liquidity. With only £225 in short-term assets (likely just a nominal bank balance), the company has no working capital to meet day-to-day demands, representing a severe case of financial anemia.
• Long-Term Creditors: £712,826 The entire financial burden is tied up in debts due after more than one year. Given that the People with Significant Control (PSC) are corporate entities (Pyx Financial Group Ltd and Westward Consultants Mayfair Limited) owning over 75% of the company, this massive debt is almost certainly intercompany loans—acting as financial life support from the parent organisations.
• Compliance Health: Overdue Confirmation Statement The company is neglecting its basic corporate hygiene. The Confirmation Statement is overdue, which is a minor symptom but indicates a lack of administrative attention to routine health checks.

Diagnosis

The financial data reveals a company that is technically insolvent on a balance sheet basis. If the creditors (likely the parent companies) were to demand repayment tomorrow, PYX MARKETS LIMITED would immediately flatline as it has only £225 to cover over £712,000 in debts.

However, because the PSCs hold the right to appoint and remove directors and own over 75% of the shares, this is almost certainly a non-trading or dormant-style holding entity within a larger corporate group. The "tumor" of £712k in debt is likely the result of accumulated historical trading losses or capital injections that were structured as loans rather than equity. The company operates with only 2 employees, suggesting it is a shell or administrative vehicle rather than a trading powerhouse.

While it does not possess a healthy pulse of its own, it is being kept alive by the broader corporate circulatory system. The consistent year-on-year increase in net liabilities suggests the parent may be continuing to fund its administrative costs via debt.

Recommendations

1. Financial Surgery (Debt-to-Equity Swap): The most critical treatment required is a capital restructuring. The parent companies should convert a significant portion of the £712,826 intercompany debt into share capital. This would heal the fractured balance sheet, bringing net assets back into positive territory and removing the stain of technical insolvency.
2. Blood Transfusion (Working Capital): The £225 in current assets is dangerously low. Even for a micro-entity with minimal operations, a small injection of cash is required to ensure basic administrative costs and filing fees can be paid without delay.
3. Restore Corporate Hygiene: Immediately file the overdue Confirmation Statement. Penalties and potential strike-off proceedings from Companies House are unnecessary complications that could easily be avoided with routine administrative care.
4. Assess Operational Purpose:Evaluate whether this entity still needs to exist. If it is no longer serving a key purpose within the Pyx Financial Group structure, the healthiest option may be to carefully wind it down and dissolve it, removing the need to maintain a chronically ill company.